Kojic acid is a natural product and normally used as a food additive and preservative, a skin-whitening agent in cosmetics, a plant growth regulator and a chemical intermediate. Using DNA microarray technology, the overall biological effects of kojic acid on the gene expression profiling of a human skin A375 malignant melanoma cells were examined. After treatment with kojic acid, a total of 361 differentially expressed genes were distinctively changed with 136 up-regulated genes and 225 down-regulated genes. We used the bioinformatics tool to search the gene ontology and category classification of differentially expressed genes that provided the useful information of expressed genes belonging to cellular component, molecular function and biological process in regulation of melanogenesis. Seven down-regulated genes of APOBEC1, ARHGEF16, CD22, FGFR3, GALNT1, UNC5C and ZNF146 that were typically validated by the real-time quantitative PCR (RT-qPCR) analysis technology showed to be the tumor suppressor genes in melanoma cancer cells. Thus, microarray technology coupled with RT-qPCR offered a high throughput method to explore the number of differentially expressed genes responding to kojic acid and their biological functions, and led to more understanding of kojic acid effects on skin cancer therapy and related side effects. Moreover, the differentially expressed genes may become useful markers of skin malignant melanoma for further diagnostic and therapeutic applications.
Kojic acid (5-hydroxy-2-hydroxymethyl-1,4-pyrone) is a secondary metabolic product and widely used as a food additive for preventing enzymatic browning of raw crabs and shrimps, [1] [2] [3] and as a skin lightening or bleaching agent for a long time in cosmetic preparations. [4] [5] [6] [7] Used as an important material in antibiotic and pesticide productions, 3, 8, 9) kojic acid has been shown to act as a competitive and reversible inhibitor of animal and plant polyphenol oxidases, xanthine oxidase, and D-and some L-amino acid oxidases. [10] [11] [12] [13] [14] [15] [16] About the toxicological aspect, the acute or subchronic toxicity resulting from an oral dose of kojic acid has never been reported, but convulsions may occur if kojic acid is injected. Continuous administration of high doses of kojic acid in mice resulted in induction of thyroid adenomas in both sexes. 8, 16, 17) Moreover, some reports showed the evaluation of the tumorigenic potential of kojic acid and study the genotoxic risk for humans using kojic acid as a skin-lightening agent. 11, [18] [19] [20] On the other hand, kojic acid at high dose has some side effects; for example, it affected thyroidal function when given at a massive dose or in a long administration period by inhibiting iodine organification in the thyroid, leading to decreases in triiodothyronine (T3) and thyroxine (T4) and increase in thyroid-stimulating hormone (TSH). [21] [22] [23] [24] Recently, kojic acid is found to be a tumor promoter and can also enhance the hepatocarcinogenesis in rat as well as in mice. 25) Moreover, the topical use of kojic acid as a skin lightening agent results in minimal exposure that poses no or negligible risk of genotoxicity or toxicity to the consumer. 18) Although kojic acid has been widely studied in the tumorigenic potential, genotoxic risk for humans and other applications, the mechanism of kojic acid on the gene expression and regulation in normal and/or diseased cells has rarely been studied.
Recently a high throughput DNA microarray technique has an important role for genomics research by allowing the study of the function of thousands of genes simultaneously, showing differential gene expression profiling, and opening the door to the discovery the biomarkers or special gene markers that intend to use for pharmaceutical applications and disease therapy. [26] [27] [28] [29] [30] In this study, we used the DNA microarray technology to investigate the biological effects of kojic acid on the differential gene expression profiling of A375-malignant melanoma cells as a model of human skin cells in order to understand the genetic basis of metabolic and cellular responses to human skin and to discover the target-based drug of new genes leading to a systematic drug development approach. In addition, we used the bioinformatics tool to search the gene ontology that provided the useful information of category classification, such as cellular component, molecular function and biological process. Moreover, we found that seven significantly expressed genes play an important role in the cancer suppression in human skin melanoma cells that may become the useful markers for diagnostic and therapeutic applications. 
MATERIALS AND METHODS

Materials
Toxicogenomics of Kojic Acid on Gene Expression Profiling of A375 Human Malignant Melanoma Cells
Sun-Long CHENG, a Rosa HUANG LIU, b Jin-Nan SHEU, a Shui-Tein CHEN, c,d Supachok SINCHAIKUL, c and Gregory Jiazer TSAY* acid, MTT (methylthiazoletetrazolium) and sodium bicarbonate were purchased from Sigma (MO, U.S.A.). RNeasy Mini Kit was purchased from Qiagen. Cyanine 3-and 5-labeled CTP were purchased from Perkin-Elemer/NEN Life Science. RNA 6000 Nano LabChip Kit, Low RNA Input Fluorescent Linear Amplification Kit, Human 1A Oligo Microarray Kit (V2), in situ Hybridization Kit Plus, and Stabilization and Drying Solution were purchased from Agilent Technologies (Palo Alto, CA, U.S.A.). All other chemicals were purchased from Sigma (MO, U.S.A.).
Cell Culture A375, human malignant melanoma cells, were cultured in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum, 1.5 g/l sodium bicarbonate, 1 mM sodium pyruvate and 1% antibiotic-antimycotic in a humidified incubator with 5% CO 2 and 95% air at 37°C. After reaching confluence, the cells were detached by treatment with 0.05% trypsin-0.53 mM EDTA. During subculture, the medium was replaced every 2 to 3 d.
Pretreatment with Kojic Acid and Cell Viability Test A375 cells were re-suspended at 5.0ϫ10 4 cells/ml in culture medium, and seeded at 5.0ϫ10 3 cells/well in 96-well tissue culture-treated plates (NUNC TM , Roskilde, Denmark) in 100 ml of culture media for an overnight in order to perform cell attachment. The cells were then washed with PBS and cultured either alone or in the presence of various concentrations of kojic acid (0.32, 1.6, 8, 40, 200 , 1000 mg/ml) for 72 h. The number of independent paired samples of cultured cells that were treated with kojic acid either present or absent was done in triplicate for each paired sample. MTT was used to assess the viability of cells following treatment. 31) Aliquots of 10 ml of stock MTT solution (5 mg/ml) were added to each well containing 100 ml of culture medium and incubated with cells for 4 h. Following incubation, the medium was removed and 100 ml DMSO were added to dissolve the precipitates of reduced MTT. The absorbances at 550 and 690 nm as reference were read on the VERSAmax TM tunable microplate reader (Molecular Devices, Sunnyvale, CA, U.S.A.). The percentage of cell growth inhibition was calculated as follows: inhibition (%)ϭ[1ϪA 550 nm (kojic acid)/A 550 nm (control)]ϫ100%.
RNA Preparation and Quantitative Measurement A375 cells were seeded at 1.0ϫ10 6 cells/dish in 10 cm tissue culture dish (NUNC TM , Roskilde, Denmark) in 10 ml of culture media for an overnight in order to perform cell attachment. The cells were then washed with PBS and treated with vehicle (DMSO, 0.01%) and kojic acid (8 mg/ml) for 24 h. RNA was extracted by a modified method using TRIzol (Invitrogen, Carlsbad, CA, U.S.A.) combined with RNeasy Mini Kit (Qiagen, Valencia, CA, U.S.A.). Briefly, total RNA was extracted with 1 ml of TRIzol reagent per 1ϫ10 6 cells or 10 cm cell culture dish following the manufacturer's instructions. For each ml of TRIzol, the samples were added with 0.2 ml of chloroform, vigorously shaken for 15 s and then incubated at 15 to 30°C for 2 to 3 min. The aqueous phase was separated by centrifugation at 12000 g for 15 min at 4°C. The supernatant was used as the input material for the RNeasy Mini Kit and the total RNA was isolated according to the manufacturer's protocol. The total RNA was quantified by a UV spectrophotometer and RNA quality was evaluated by capillary electrophoresis on an Agilent 2100 Bioanalyzer using RNA 6000 Nano LabChip Kit.
RNA Amplification and Labeling
Each total RNA from each paired sample treatment was pooled and amplified to obtain the cRNA in order to avoid variations of each experiment in sample preparations or hybridization steps. Briefly, targets of cRNA were amplified and fluorescently labeled from 0.5 mg total RNA in each reaction using the Agilent Low RNA Input Fluorescent Linear Amplification kit by following the protocol described in the user's manual. For each sample pair, control sample was labeled with Cy3 and treated with Cy5. Briefly, 1.2 ml of T7 promoter primer was added to a 1.5 ml microcentrifuge tube containing 0.5 mg total RNA and final volume was adjusted to 11.5 ml with nuclease-free water. The primer and the RNA template were denatured at 65°C in a heating block for 10 min and cooled on ice for 5 min. A volume of 8.5 ml of cDNA master mix was added to each reaction tube. The cDNA synthesis reaction mix contains 4 ml of 5ϫ first strand buffer, 2 ml of 0.1 M DTT, 1 ml of 10 mM dNTP mix, 1 ml of MMLV-RT, and 0.5 ml of RNaseOUT. Samples were incubated at 40°C in a circulating water bath for 2 h, heated at 65°C for 15 min (to inactivate MMLV-RT) and cooled on ice for 5 min. A volume of 2.4 ml of 10 mM cyanine 3-CTP or cyanine 5-CTP was added to each sample tube, followed by the addition of 57.6 ml of transcription master mix. The transcription master mix contained 15.3 ml of nuclease-free water, 20 ml of 4ϫ transcription buffer, 6 ml of 0.1 M DTT, 8 ml of NTP mix, 6.4 ml of 50% PEG, 0.5 ml of RNaseOUT, 0.6 ml of inorganic pyrophosphatase and 0.8 ml of T7 RNA polymerase. The reaction mixture was then incubated at 40°C for 2 h. Following the Qiagen protocol; labeled cRNA was purified using Qiagen's RNeasy mini-spin columns. The cRNA product was eluted with nuclease-free water from the column in 2ϫ30 ml of final volume. The quality and size distribution of cRNA targets were determined by RNA 6000 Nano LabChip Assay, and quantitation was determined by ultraviolet (UV) spectrophotometry.
Microarray and Hybridization Hybridization was performed following the Agilent oligonucleotide microarray hybridization user's manual and Agilent in situ Hybridization Kit Plus. Briefly, 2 mg of labeled cRNA per channel was mixed with 50 ml 10ϫ control targets and nuclease-free water to a final volume of 240 ml. Then 10 ml of 25ϫ fragmentation buffer was added to each sample tube and reactions were incubated at 60°C in a water bath, in the dark for 30 min. The addition of 250 ml of 2ϫ hybridization buffer terminated the reaction. A volume of 500 ml of hybridization mix was applied to each of Agilent's human 1A oligonucleotide microarray, containing approximately 20173 (60-mer) oligonucleotide probes, which span conserved exons across the transcripts of 18716 targeted full-length genes (Agilent Tech., Mississauga, ON, Canada) and hybridized in a hybridization rotation oven at 60°C for 17 h. The slides, disassembled in 6ϫ SSPE and 0.005% N-lauroylsarcosine, were washed first with 6ϫ SSPE, 0.005% N-lauroylsarcosine for 1 min at room temperature, then with 0.06ϫ SSPE and 0.005% N-lauroylsarcosine for 1 min and with Stabilization and Drying Solution for 30 s.
Scanning and Gene Expression Analysis The microarray chip was scanned using Agilent G2565BA Microarray Scanner System. The arrays were scanned using the Agilent dual laser DNA microarray scanner with SureScan technol-ogy. The information was extracted from images by Agilent's Feature Extraction software 7.5 using defaults for all parameters. Following to the instruction protocol of Agilent G2567AA Feature Extraction software (v.7.1), the significance (P-values) of log ratios was computed by using a parameterized error model. The image quantities of interest produced by the image analysis methods were the (R, G) fluorescence intensity pairs for each gene on each array probe, where Rϭred for Cy5 and Gϭgreen for Cy3. An 'MA-plot' was used to represent the normalized (R, G) data, where Mϭlog R/G and Aϭlog √ෆ RϫG. 32, 33) For the bioinformatics tool used for searching gene ontology, we used the combination of databases to access the information such as gene name, gene symbol, subcellular location, family and superfamily classification, chromosome map location, similar gene, molecular function, biochemical function related protein and references. The gene search programs were used the following sequential order of databases: NCBI (http://www.ncbi.nlm.nih.gov), Ensembl (http://www.ensembl.org), TIGR (http://www. tigr.org), and GeneCards (http://bioinfo.weizmann.ac.it/cards/index.shtml). In addition, the category classification of gene expression was done by in-house BGSSJ (Bulk Gene Search System for Java; http://servx8.sinica.edu.tw/bgss-cgi-bin/gene.pl) program which is a searching system accomplished by open database connectivity that integrates UniGene, Swiss-Prot, NCBI and PubMed databases to correlate and simplify data analysis of gene ontology. On the other hand, the protein search programs were used the following databases: SwissProt/TrEMBL (http://www.expasy.ch/sprot), Proteome (http: //www.proteome.com/databases/HumanPD/ reports) and PubMed (http://www.ncbi.nlm. nih.gov/PubMed).
Real-Time Quantitative PCR (RT-qPCR) Analysis Specific oligonucleotide primer pairs were designed with the analysis Beacon designer 4.00 (Premier Biosoft International) and used for real-time PCR. The sequences of the primers used are shown in Table 1 . The specificity of each primer pair was tested by using common reference RNA (Stratagene) to perform RT-PCR reaction and followed by DNA 500 chip run on Bioanalyzer 2100 (Agilent Technologies) to check the size of the PCR product. Primer pairs of production predicted product size and no other side-product were chosen to conduct the following SYBR reaction.
Real-time quantitative PCR (RT-qPCR) was performed on the LightCycler instrument 1.5 (Roche) using LightCycler ® FastStart DNA Master PLUS SYBR Green I kit (Roche Applied Science). Briefly, 10 ml reactions contained 2 ml Master Mix, 2 ml of 0.25 mM gene specific primer, and 6 ml of cDNA, generated as described above. Each sample, which consisted of cDNA generated from all the samples as detailed above, was run in duplicate. The PCR parameters were 95°C for 10 s, 45 cycles of 95°C for 10 s, 60°C for 3 s and 72°C for 10 s. At the end of the program a melt curve analysis was made. At the end of each PCR run, the data were automatically analyzed by the system and an amplification plot was generated for each cDNA sample. From each of these plots, the LightCycler software calculated the threshold cycle (Cp), defined as the fractional cycle number at which the fluorescence reached the baseline. The fold expression or repression of the target gene relative to b-actin in each sample was then calculated by the formula: 2
ϪDDCp where DDCpϭDCp kojic acid sample Ϫ DCp control sample , DCp kojic acid sample ϭCp kojic acid-stimulated target gene Ϫ Cp kojic acid-stimulated b-actin and DCp control sample ϭCp control target gene Ϫ Cp control b-actin .
RESULTS
Inhibition Effect of Kojic Acid on A375 Melanoma
Cells The examination of kojic acid effect on cell growth inhibition of A375 melanoma cells showed that the cell growth of A375 melanoma cells was directly inhibited by the increase of kojic acid concentrations. After treatment with kojic acid for 72 h, the highest concentration of 1000 mg/ml kojic acid allowed the inhibition of A375 cells less than 40% while the lower concentrations of 0.32, 1.6, 8 and 40 mg/ml kojic acid only allowed the inhibition of A375 cells less than 20% (Fig. 1) . It indicated that the cell growth inhibition of A375 cells was not strongly effected by all concentrations of kojic acid. In addition, there was no morphological change of A375 cells along 24 h in the presence of 8 mg/ml kojic acid, which was referred as the mild concentration or recommended dosage of kojic acid for human skin safety. 3) In order to study the early-stage of stimulation effect of kojic acid on gene expression profiling of A375 cells, compatible with the human skin therapy, we decided to choose the time point at 24 h-treatment for the following microarray analysis.
Microarray Analysis of Differential Gene Expression in A375 Cells after Kojic Acid Treatment Messenger RNA from control and kojic acid-treated A375 cells were labeled with Cy3-or Cy5-dCTP, respectively, using a single round of reverse transcription and hybridization with the oligonucleotide microarray chip. The microarray results showed different fluorescence intensities of Cy3 and Cy5, depending on the differential gene expression level. The comparative fluorescence intensities of Cy3 and Cy5 are represented in the MA-plot, in which those spots show markedly significant genes between the Cy3 and Cy5 signals in P-value less than 0.01 (pϽ0.01) (Fig. 2) . Analysis of gene expression changes in kojic acid-stimulated A375 cells at the RNA level using human 1A oligonucleotide microarray complementary to 20173 (60-mer) oligonucleotide probes showed the total number of 433 differentially expressed probes that were matched with the gene list approximately 361 genes, containing 136 up-regulated genes (Table 2 ) and 225 down-regulated genes ( Table 3 ). The 24-h kojic acid treatment was the earlyphase stimulated time scale for gene to turn on and the microarray data represented the differential expression genes in kojic acid-stimulated A375 cells. In addition, we used the bioinformatics tools combining NCBI, Ensembl, TIGR and GeneCards database to access the gene information that provided the description of the expressed genes from the microarray data. Moreover, we also used the in-house BGSSJ program to search the gene ontology that classified the gene category into three main groups according to cellular component, molecular function and biological process. The summary of category classification of differentially expressed genes in kojic acid-stimulated A375 cells is shown in Fig. 3 . Only 75 up-regulated genes and 123 down-regulated genes were classified by BGSSJ program and showed the different ratios of subcategories in each group of expressed genes. Some of genes could be classified into more than two categories, depending on their cellular component, molecular function and biological process. The expressed genes were found to locate in the subcellular region rather than organelle, extracellular region, protein complex and extracellular matrix, respectively. It may indicate the signal transduction pathway occurred from extracellular region to intracellular region because some of genes were also found in both re- 
Fig. 2. Microarray Data Represents M-A Plot of Differentially Expressed Probes of Kojic Acid Responded Genes in A375 Cells
cRNA targets were amplified and labeled using total RNA from A375 cells treated with 8 mg/ml kojic acid and the Agilent Low RNA Input Fluorescent Linear Amplification Kit. Cyanine 3-and cyanine 5-labeled targets were then combined and hybridized to an Agilent Human 1A oligonucleotide (V2) microarray using the Agilent in situ Hybridization Kit. M-A plot for a representative probe of comparative experiments (normal mRNA labeled with Cy3 and kojic acid-treated mRNA labeled with Cy5) where Rϭlog(Cy5/Cy3) represents the common log ratio of the two dyes and Aϭ[log(Cy5)ϩlog(Cy3)]/2 is the average logarithmic fluorescence intensities of both channels. The gene expression pattern shows over 433 significantly differentially expressed probes (pϽ0.01). Blueϩ represents any data point whose log ratio is not significantly different from 0; redϩand greenϩrepresent data points whose log ratios are greater or less than 0, respectively (pϽ0.01). gions. Otherwise, they possessed the molecular functions in different ratios of binding, catalytic activity, signal transducer activity, transcription regulator activity, enzyme regulator activity, transporter activity, structural molecule activity and translation regulator activity. The different ratio of biological functions of expressed genes may indicate the correlated function in regulation of melanogenesis. Moreover, the expressed genes involved some biological processes, such as physiological process, cellular process, regulation of biological process and development, leading to understand the related malignancy processes in melanogenesis. Thus, this category classification provided more useful information of gene ontology in response to kojic acid stimulation and indicated that all of differentially expressed genes are regulated by various gene networks and play the related molecular functions involving biological processes in the regulation of melanogenesis.
RT-qPCR Validation of Array Analysis
The significant expressed genes chosen for RT-qPCR examination were determined a mean degree of regulation with pϽ0.01 by array analysis. The differentially expressed genes were searched the biological functions correlated with carcinogenesis and selected the significant expressed genes following to the order of P values. The selected genes were validated by RTqPCR analysis to confirm the result of gene expression with microarray data. The RT-qPCR results showed the perfectly matched gene expression levels of seven expressed genes in kojic acid-stimulated A375 cells in agreement with the DNA microarray expression data. Seven genes for RT-qPCR examination were apolipoprotein B RNA editing deaminase gene (APOBEC1), 34) Rho guanine exchange factor (GEF) 16 (ARHGEF16), 35) CD22 antigen (CD22), 36) fibroblast growth factor receptor 3 (FGFR3), [37] [38] [39] [40] UDP-N-acetyl-alpha-Dgalactosamine: polypeptide N-acetylgalactosaminyl transferase I (GALNT1), 41, 42) netrin receptor UNC5C precursor (UNC5C) 43) and zinc finger protein 146 (ZNF146). [44] [45] [46] The comparison of gene expression level of seven differentially expressed genes by microarray and RT-qPCR is shown in Table 4 . Those genes were down-regulated in kojic acid-stimulated A375 cells and possessed the function of tumor suppressor in the regulation of carcinogenesis mechanism. In addition, seven of differentially expressed genes were also classified by BGSSJ program and showed the localization in subcellular and/or extracellular region, where FGFR3, GALNT1 and UNC5C genes may occur the signal transduction from extracellular region into cellular region (Fig. 4) . They play the molecular functions in binding, catalytic activity and signal transducer activity and also involved in the biological processes, such as physiological process, cellular process, regulation of biological process and development, which may regulate the malignancy of melanogenesis. 664 Vol. 29, No. 4 
DISCUSSION
Although some of the biological applications and potential effects of kojic acid have been partially elucidated, 19, 25, 47, 48) the intensive study of kojic acid effect on human genomics level including gene regulatory mechanism is not clear and rarely reported. In this study, we used the human skin A375 malignant melanoma cells to examine the genotoxicity effect of kojic acid on carcinoma therapy, except skin whitening effect. To examine the genotoxicity effect of kojic acid on gene expression profiling of A375 cells, the microarray technology providing the high throughput method for easily screening the number of differentially expressed genes was used. It has been used for analysis of gene expression in dermatology including human melanomas, [49] [50] [51] [52] [53] [54] however, the study of gene expression profiling in kojic acid-stimulated A375 cells by DNA microarray has never been reported. Therefore, it is very challenging to use the high throughput technology of DNA microarray for studying the effect of kojic acid on the large numbers of differentially expressed genes of A375 melanoma cells and functional regulations on anti-tumorigenesis in malignancy of melanoma. In addition, the reasons that used the human 1A oligonucleotide microarray to analyze gene expression of human skin A375 melanoma cells were: (i) Human 1A oligonucleotide microarray is comprised of 20173 oligonucleotide probes, which span conserved exons across the transcripts of the 18716 human genes. This human gene analysis system is compatible with the human skin A375 melanoma cells and could screen the large numbers of human differentially expressed genes in once time.
(ii) Human 1A oligonucleotide microarray used convenient two-color labeling procedure that reduces experimental variability by allowing biological samples to be directly compared with each other on the same microarray after undergoing the same hybridization incubation. Thus, this microarray platform allows to analysis of kojic acid-responded genes in A375 cells that may become the gene markers in the malignancy of melanoma for diagnostic and therapeutic applications on human skin.
For the cell treatment, we examined the various concentrations (0.32, 1.6, 8, 40, 200, 1000 mg/ml) of kojic acid on the growth inhibition of A375 cells. All of kojic acid concentrations did not strongly inhibit the cell growth of A375 cells even though the incubation time was longer (72 h). By using microarray technology to study the overall effects of kojic acid on whole gene expression of A375 cells, we used the kojic acid at the concentration of 8 mg/ml (0.8%) because this is the mild concentration that could inhibit A375 cells with the inhibition less than 20% and avoid the differential gene expression data resulting from cell death response of cytotoxicity of high concentration of kojic acid. Moreover, the safety of kojic acid for human skin care products is recommended for general use at a concentration up to 1% without prescription.
3) Under this consideration, the concentration of 8 mg/ml kojic acid (0.8%) is safe for human skin and can be used to study the gene expression profiling in A375 cells and through the regulatory functions of differentially expressed genes on carcinogenesis therapy.
According to the microarray data, we used the bioinformatics tools to identify the differentially expressed genes and search the gene ontology that provided the useful information of category classification consisting of cellular component, molecular function and biological process. The obtained information can be used as indicators for studying the further regulatory mechanisms and applications of gene markers for early cancer diagnostics and therapy. For the number of differentially expressed genes, we have selected the significant genes correlated to the carcinogenesis and also used RT-qPCR for validating gene expression changes, comparing microarray analysis data. RT-qPCR offered the confirmatory quantitative results under stringent condition and showed the quantitative of kojic acid-responded genes in agreement with the DNA microarray expression data. It indicated that our validated genes in the robust biomarkers lists obtained precise data, in which the validated genes may become the useful biomarkers to understand the biochemistry of drug-molecular response in the future clinical researches. Interestingly, we found seven significant kojic acid-responded genes that were down-regulated in kojic acid-stimulated A375 cells. Most of genes are highly related to the regulation of carcinogenesis process.
APOBEC1 (Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1) is the central component of an RNA editosome whose physiological role clearly lies in deamination of apoB mRNA C6666 to U in gastrointestinal tissues, thereby creating a premature stop codon. 55, 56) Uncontrolled cytidine deamination could generate inappropriately folded polypeptides, dominant-negative proteins, or mutations in tumor suppressor genes and thus contribute to tumor formation process. 57, 58) Then, the overexpression of APOBEC1 has led to the development of a number of different cancers, such as gastrointestinal cancer, colon cancer and heptocellular cancer, in a variety of tissues. It implies that any inappropriate expression of a member of the DNA deaminase family can have potential oncogenic activity. 59, 60) Furthermore, most of human carcinomas were caused by APOBEC1 mediated mRNA editing. [61] [62] [63] Thus, the down-regulated APOBEC1 may potentially allow deactivating the tumor progression of A375 melanoma cells. ARHGEF16 (Rho guanine exchange factor (GEF) 16) is one of the multiple GEF members that have a crucial role in activating small GTPase by exchanging GDP for GTP and regulate various cellular functions including actin cytoskeleton organization, activation of kinase cascades, mitogenesis, transcriptional activation and stimulation of DNA synthesis. 35) Although the specific function of this gene is not yet known, it is regarded to be involved in protein-protein and protein-lipid interactions. In addition, some reports in cancer research showed that Rho signaling and PI 3-kinase activation play an important role in regulating breast tumor progression. 64, 65) Moreover, a novel putative human Rho GEF designated Src homology 3 (SH3) domain-containing guanine nucleotide exchange factor (SGEF) provides a direct link for cross-talk between the androgen receptor and Rho GTPase signaling pathways in prostate cancer cells. 66) In consequence, the down-regulated ARHGEF16 gene by kojic acid may suppress or deactivate the tumor progression of A375 melanoma cancer cells.
CD22 encoding CD22 antigen, which is a type I integral membrane sialoglycoprotein with a molecular weight of 135 kDa, is found specifically on cancerous B-lymphocytes where it is initially present in the cytoplasm of developing Bcells and later expressed on the cell surface of mature Bcells. 36, [67] [68] [69] Preclinical CD22 has been shown to be an effective target for immunotherapy of B-cell malignancies using either "naked" or toxin-labeled or radio-labeled monoclonal antibodies. CD22 is strongly expressed in hairy cell leukemia and variants and anti-CD22 therapy has been shown to have a high response rate in refractory hairy cell leukemia. 70, 71) The down-regulated CD22 by kojic acid may suppress or deactivate the tumor progression of melanoma cancer cells and be related to the immune response of human skin cell.
FGFR3 (fibroblast growth factor receptor 3) is one of four high affinity tyrosine kinase receptors for the FGF family of ligands. On ligand stimulation, FGFR3 undergoes dimerization and tyrosine autophosphorylation that result in cell proliferation or differentiation, depending on the cell context. The results are processed through the mitogen-activated protein kinase (MAPK) and phospholipase Cg signal transduction pathways. 40) The extracellular portion of the protein encoded by FGFR3 gene interacts with fibroblast growth factors, sets in motion an acidic and basic fibroblast growth hormone and plays a role in bone development and maintenance. 72, 73) The inhibition of FGFR3 also induced differentiation and apoptosis in multiple myeloma activated FGFR3 is also an oncogene that contributes to tumor progression in multiple myeloma including human breast cancer. [37] [38] [39] According to our finding of down-regulated FGFR3 gene, it is supported that the down-regulation of FGFR3 may deactivate the tumor progression of malignant transformation in melanoma cells.
GALNT1 (UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 1, GalNAc-T1) transfers an N-acetyl galactosamine (GalNAc) to a serine or threonine residue in the first step of O-linked oligosaccharide biosynthesis. 41, 42) GALNT1 has been reported to have a ubiquitous expression in all gastric carcinoma cell lines. It suggests that the differential expression of GalNAc transferases underlies the mechanism responsible for altered carbohydrate antigen expression observed in gastric, colorectal and epithelial cancers. 41, 42, 74) Thus, the down-regulated GALNT1 by kojic acid also potentially allows deactivating the tumor progression of A375 melanoma cells.
UNC5C as netrin-1 receptor was initially proposed as mediator of the chemopulsive effect of netrin-1 on specific axons. The expression of the human UNC5C is down-regulated in multiple cancers including colorectal, breast, ovary, uterus, stomach, lung, or kidney cancers. [75] [76] [77] Interestingly, our finding showed that this gene was strongly down-regulated in kojic acid-stimulated A375 cells, rather than the normally untreated A375 cells. Although the signal downstream of the UNC5C receptor in either axon guidance or apoptosis is not clear, most of published papers showed that the UNC5 family acts as putative tumor suppressor because of their frequent alteration in various human cancers. 77, 78) Thus, we expected that the expression reduction of this gene in kojic acid-stimulated A375 cells might promote the tumor-suppressor-gene in deactivation of carcinogenesis process. Likewise, it has been reported that the removal of the netrin binding second Ig domains of UNC5C caused an increase of UNC5C in the basal tyrosine phosphorylation, occurring during melanoma progression at the stage when cells first become competent for metastasis. 79, 80) ZNF146 or human OZF gene, located in chromosome band 19q13.1, is overexpressed in the majority of pancreatic cancers with more than 80% of colorectal cancers. [44] [45] [46] ZNF146 encoding protein consisted of ten Kruppel zinc finger motifs, called zinc finger protein OZF. It has been reported that the high-level expression of ZNF146 is frequent in pancreatic carcinomas and may contribute to the development or progression of this tumor. Thus, the down-regulated ZNF146 gene by kojic acid may allow deactivating the tumor progression in A375 melanoma cells.
In conclusion, we used the high throughput analysis of DNA microarray and RT-qPCR for global analysis of differentially expressed genes responding to kojic acid in A375 human melanoma cells. The differentially expressed genes were classified the category, depending on cellular component, molecular function and biological process, and led to explore the more valuable data in the regulation of melanoma carcinogenesis against kojic acid. In addition, seven downregulated genes showed significantly differential expression in A375 cells after kojic acid treatment and played the function as tumor suppressors that may deactivate the regulation of melanoma tumorigenesis in human malignant melanoma cells. These genes may become the useful markers for further diagnostic and therapeutic applications. Moreover, our findings also showed the probably side effects or disadvantages of kojic acid on the dysfunction of immune system and bone development and maintenance. However, we will further study the effects of kojic acid on biological and molecular mechanisms of human melanoma skin cells, including other parts of human body, and also examine other biological characterization of kojic acid in the cosmetic and/or therapeutic applications.
